The Vanderbilt Institute for Global Health (VIGH) has received a new research grant from the National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIH to establish a large childhood status epilepticus (SE) cohort in northern Nigeria with key partners Aminu Kano Teaching Hospital (AKTH) and Bayero University, and with the Sydney Brenner Institute for Molecular Bioscience at the University of the Witwatersrand (Wits) in South Africa.

The Vanderbilt Institute for Global Health (VIGH) has partnered with Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria to improve epilepsy treatment uptake. The groups will conduct a randomized trial in three cities in northern Nigeria to determine the efficacy of shifting epilepsy care to community health workers.

The Vanderbilt Institute for Global Health, with Aminu Kano Teaching Hospital, will conduct a 60-site cluster randomized clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers with a five-year $5.9 million federal grant, “Bridging the Childhood Epilepsy Treatment Gap in Africa (BRIDGE),” from National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Edwin Trevathan, M.D., M.P.H., Amos Christie Chair in Global Health, Professor of Pediatrics and

​VIGH Director Edwin Trevathan, M.D., M.P.H., was awarded the Amos Christie Chair at a ceremony on April 25. At this event, Dr. Trevathan and seven other faculty members were named to endowed chairs.